Melanoma is one of the most common kinds of cancer. The chance of getting melanoma increases with age, although it can affect people of all ages. It is the most serious of all types of skin cancer.
INTRON® A (Interferon alfa-2b, recombinant) for Injection is indicated as adjuvant to surgical treatment in patients 18 years of age or older with malignant melanoma who are free of disease but at high risk for systemic recurrence within 56 days of surgery.
Are you already starting treatment for melanoma? Find ideas for planning ahead, talking to family and coworkers, setting up your support team.